Deltaretrovirus infections
MONDO:0021184Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).
Also known as: BLV infection, BLV infections, Deltaretrovirus infection, HTLV BLV infections, HTLV infection, HTLV infections, HTLV-BLV infection, HTLV-BLV infections
35 clinical trials for this condition and its sub-types, 1 tagged with Deltaretrovirus infections itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Deltaretrovirus infections
-
Adult T-cell leukemia/lymphoma 31 trials
-
HTLV-2 infection 0 trials
-
Experimental lymphoma drug ASTX660 tested in tiny, terminated trial
Disease control Stopped earlyThis early-phase trial tested the drug ASTX660 in just 8 people with T-cell lymphoma that had returned or not responded to prior treatments. The study aimed to find a safe dose and check for side effects, but it was stopped early. Because it was so small and incomplete, we cannot…
Phase 1/2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Promising combo for tough blood cancers halted early — only 4 patients enrolled
Disease control Stopped earlyThis study tested whether adding rapamycin to high-dose chemotherapy could help people with aggressive blood cancers (like certain leukemias and lymphomas) that had returned or not responded to prior treatment. Only 4 adults aged 18–65 took part before the study was stopped early…
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC